Protein-Ligand Interactions - II  by unknown
(precursor of BNP which has additional 76 residues at the N-
terminus). The dissociation constants and binding kinetics of an-
ti-BNP mAb and the three forms of BNP derivatives were deter-
mined by FCS and fluorescence quenching. Comparisons of the
thermodynamics results on the three forms of BNP provide insights
on how the size and conformation of the antigen affect the antigen-
antibody interactions.
1050-Pos Adiabatic Compressibility
Variation During Amphiphile Binding
To Bovine Serum Albumin
NajwaElKadi1,Nicolas Taulier1,WladimirUrbach2,Marcel
Waks1
1CNRS, Paris, France
2ENS, Paris, France.
Board B26
Serum albumin, the most abundant transport protein in the circula-
tory system, is made of three structurally homologous, predomi-
nantly alpha-helical domains. These domains denominated I, II and
III, share the two primary protein binding sites existing for a wide
variety of ligands/drugs. Since it has been crystallized, the protein
has therefore attracted a renewed interest for the understanding of its
drug transport and delivery mechanism. We present here the ultra-
sonic characterization of bovine serum albumin (BSA) during the
binding of amphiphile molecules: a cationic surfactant cetylmethyl
ammonium chloride (CTAC) and a fatty acid myristic acid (myr).
We have investigated BSA by densimetric studies and adiabatic
compressibility determinations and monitored the resulting confor-
mational changes by circular dichroıˆsm. We have investigated first
the BSA adiabatic compressibility as a function of CTAC concen-
tration. The compressibility increases up to a CTAC/protein molar
ratio of 20, decreasing then for higher ratio values. This result has
been interpreted in terms of surfactant binding, water release,
protein unfolding and/or aggregation. At the same time the al-
pha-helical content of BSAwas decreasing starting at a ratio around
20. In contrast, volumetric measurements of myristic acid binding
reveal amaximumat amyr/BSAmolar ratio of 7,which corresponds
precisely to the maximum number of binding sites as reported by
recent NMR studies. At higher ratio values, a very slow decrease of
the compressibility is observed, which might be interpreted by the
formation of myr micelles. The binding does not induce observable
changes in BSA secondary structure. These results are of value for
the design and the developpement of new, tailor-made drug carriers,
an important area for future research.
1051-Pos Mutations In PTEN’s
Phosphatase Domain Affect Binding To
Phosphatidylinositol-4,5-bisphosphate
and Phosphatidylserine
Roberta E. Redfern1, Alonzo Ross2, Arne Gericke1
1Kent State University, Kent, OH, USA
2University of Massachusetts Medical School, Worcester, MA, USA.
Board B27
PTEN is a phosphatase specific for the 3 position of the phoso-
phoinositide ring that is deleted ormutated inmanydifferent disease
states. PTENassociationwithmembranes requires the interaction of
its C2 domain with phosphatidylserine (PS) and most importantly,
the interaction of its N-terminal end with phosphatidylinositol-4,5-
bisphophate (PI(4,5)P2).We have shown that the latter interaction is
specific for PI(4,5)P2 over all other phosphoinositides and this
binding specificity is maintained for a short peptide representing
PTEN’s first 21 amino acids (PTEN1–21).We hypothesize that some
disease relevant mutations affect the extent and/or specificity of
PTEN’s binding to PI(4,5)P2 or PS. We have shown that one
particular cancer relevant mutation, K13E, leads to a loss of PTEN
binding to PI(4,5)P2, suggesting that the lysine in the 13 position is
critical for binding.We have investigated several mutants that either
vary the nature of the amino acid in the 13 position or alter the
position of the lysine by switching it with neighboring amino acids.
All mutations encountered abrogate binding of PTEN1–21 to PI(4,5)
P2 and abolish specificity. Importantly, many of these mutations
maintain the overall charge of the peptide, highlighting that the
interaction between PTEN and phosphoinositides is specific and not
governed only by non-specific electrostatic interactions. PTENH93R
is an autism relevant mutation in PTEN’s phosphatase domain
associated with a complete loss of in vivo activity. Our results
indicate that this mutant protein binds more strongly to PS than the
wild type protein and that the protein undergoes different confor-
mational changes upon interactions with lipids than the wild type
protein.We hypothesize that a new PS binding site is created by this
mutation and that the strong binding prevents PTEN from
“hopping”, which limits PTEN’s substrate access and reduces its
activity.
Protein-Ligand Interactions - II
1052-Pos Carbohydrate recognition by
anti-viral proteins
David F. Green
Stony Brook University, Stony Brook, NY, USA.
Board B28
The surfaces of many enveloped viruses are heavily glycosylated to
avoid an immune response; the HIVenvelope glycoprotein gp120 is
a perfect example. This creates many challenges to the effective
inhibition of viral-cell recogition, but also provides unique oppor-
tunities. Over the past several years, a number of prokaryotic
proteins have been shown to inhibit HIV cell-entry by binding to
gp120; these proteins specifically recognize the carbohydrate por-
tion of the glycoprotein. Despite a number of structural and bio-
chemical studies, a complete understanding of the origins of affinity
and specificity for diverse carbohydrate targets has yet to be
developed.
Using a range of computational approaches, we have developed
detailed models of carbohydrate binding to the best-studied of these
proteins, Cynanovirin-N. The known differences in binding affini-
ties of a series of oligosaccharides are well-matched by calculations
based on these models, and can be explained in simple structural
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terms. The models additional provide insight into the mechanisms
of multi-valent binding — a key property of these systems. A
computational protein design protocol has further been able to
suggest possible variants of Cyanovirin-N with enhanced affinity
and specifity for a number of carbohydrate targets.
Work is on-going to extend these studies on Cyanovirin-N to the
less-well characterized anti-viral proteins. In addition, the method-
ologies and insights developed through these studies may be
applicable to a diverse set of problems in the molecular interactions
of glycoproteins.
1053-Pos Drug Discovery for HIV-1
NCp7 and Structural Analysis Using
NMR
Lingchun Yang, Deborah Kerwood, Philip N. Borer
Syracuse University, Syracuse, NY, USA.
Board B29
The Human Immunodeficiency Virus (HIV), responsible for the
Acquired Immunodeficiency Syndrome (AIDS), is a member of the
retroviral family. The nucleocapsid (NC) domain of the Gag pre-
cursor is critical for the recognition and packaging of the viral
genome and appears to be important for viral particle formation.
Structural analysis of NCp7 by NMR has already provided clues
about the NC binding mechanism and suggested tools to defeat
AIDS. When a drug candidate binds the protein, the electronic
environment of the protein’s binding site changes and results in
perturbation of the chemical shifts of nuclei at that site. Two-
dimensional 1H-15N heteronuclear single-quantum correlation
(HSQC)-NMR spectroscopy can be used to screen for ligand
binding by detecting the amide signals of the 15N-labeled protein.
Based on previous research in our group, 22 compounds (D1-D22)
from the NCI Diversity set were found to interfere with NCp7
binding to the HIV-RNA packaging signal. The HSQC spectra of a
series of ligands bound to NC have been obtained. The primary
analyses show that D9 can bind with NCp7 and change the structure
of NCp7 gradually with increasing ratio and finally denatures the
protein when the molar ratio, D9:NCp7 is 8:1([NCp7]¼0.1mM).
D7, D8, and D11 also can denature NCp7 when the ratio is above
4:1. The comparison of HSQC spectra between free NCp7 and
NCp7 bound with D17 or D19 proves that D17 or D19 first reacts
with the second zinc finger, then the first zinc finger, and finally
denatures the protein. These results suggest that these compounds
may become the promising drugs which can interact with zinc
fingers and change the structure of NCp7.
(D7¼NSC 48300, D8¼NSC 305787, D9¼NSC 107684,
D11¼NSC 65238, D17¼NSC 305819, D19¼NSC 13950)
1054-Pos Agonist/Antagonist Sensor in
Opioid Receptors - Molecular Modeling
Study
Michal Kolinski, Slawomir Filipek
International Institute of Molecular and Cell Biology, Warsaw, Poland.
Board B30
Opioid receptors belong to a large superfamily of G protein-coupled
receptors (GPCRs). These receptors are essential for signaling
across plasma membranes. Each GPCR responds to a single or
multiple ligands by activating G proteins and thus giving rise to a
highly amplified signaling cascade. GPCRs represent the largest and
most versatile family of membrane receptors. Although so different
in action all these receptors share the same topology - a bundle of
seven transmembrane a-helices. Activated receptor undergoes con-
formational rearrangements leading to transmitting the signal to cell
interior.
Opioid receptors (mu, delta and kappa) belong to family A
(rhodopsin-like) of GPCRs. For the important role they play in the
human body in controlling pain and stress, modulating immune
responses and developing addiction the opioid receptors were
subject of numerous investigations.
The first event in opioid receptor activation includes sensing of
agonists and antagonists. To investigate this effect at the atomic
level we chose a set of rigid ligands based on the structural motif of
tyramine. Four antagonists were used and three agonists including
morphine. Opioid receptors and their complexes were simulated in
the membrane. Based on simulated annealing and molecular dy-
namics methods we propose a distinct mode (a sensor) of binding of
antagonists and agonists in the active site of opioid receptors. The
phenolic hydroxyl group of antagonists was bound toY3.33 and that
of agonists to H6.52. All analyzed agonists broke a hydrogen bond
D3.32-Y7.43 and thus weakened the connection between trans-
membrane helices 3 and 7.Moreover, when antagonist was forced to
bind H6.52 it also broke D3.32-Y7.43 in all opioid receptors.
Supported by MNiSW grants N-N301-2038-33 and N-N401-
1401-33.
1055-Pos Coarse-Grained Modeling of
Signal Transduction in Beta2
Adrenergic Receptor
Ilya A. Balabin, David N. Beratan
Duke University, Durham, NC, USA.
Board B31
Beta2 adrenergic receptor (B2AR) is a G-protein coupled receptor
(GPCR) targeted by the catecholamines. Activating ofB2ARcauses
smooth muscle relaxation resulting in dilation of bronchial pas-
sages, vasodilation in muscle and liver, relaxation of uterine muscle
and release of insulin. Thanks to this function, B2AR is a prime
pharmaceutical target is asthma therapy. However, B2AR agonists
are also known to cause side effects such as increased heart rate and
blood pressure, suggesting multiple signaling channels. Under-
standing the structural basis of signal transduction in B2AR will
be immensely helpful in minimizing side effects of drugs that target
the receptor. We perform a coarse-grained analysis of the B2AR
structural motions induced by ligand binding. Effects of agonists
and antagonists are explored, and strategies for designing new drugs
to target B2AR are discussed.
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1056-Pos Molecular Modeling of
Syringomycin-E - membrane
interactions
Edit Matyus, D. Peter Tieleman
University of Calgary, Calgary, AB, Canada.
Board B32
Syringomycin-E (SR-E) is a cyclic lipodepsipeptide produced by
certain strains of the bacteriumPseudomonas syringae pv. syringae.
It shows inhibitory effects against many fungal species, including
human pathogens. Its primary biological target is the plasma
membrane, where it forms channels comprised of at least six SR-
E molecules. The asymmetric channel appears to directly incorpo-
rate 40 lipid molecules. The high-resolution structure of SR-E in
solvents and the structure of the channels are currently not known.
Studies of the SR-E channel structure may result in a better
understanding of its biological activity.
We investigated in atomic detail themolecular features of SR-E in
hydrophilic, hydrophobic and lipid bilayer environments by molec-
ular dynamics simulation (MD). As a first step we built a model of
SR-E and examined its structure in water and octane in 200 ns MD
simulations including distance restraints derived from NMR NOE
data.Wedetermined structural preferences of SR-E in both solvents,
in particular the importance of side-chain interactions in determin-
ing peptide stability. SR-E exists in two dominant structures whose
relative probabilities depend on the polarity of the solvent, in
agreement with published experimental data. These three-diman-
sional structures are used as a basis to investigate the interactions of
SR-E with lipid membranes.
Activity of SR-E is significantly influenced by the lipid compo-
sition of the membrane, and they play a crucial role in channel
gating. To study the influence of lipid charge and shape on peptide-
lipid interactions and on pore formation we built DOPE and DOPS
bilayers and incoporated six SR-E molecules in each lipid bilayer.
These bilayer systems were simulated by longMD simulations. The
results of trajectory analyses will be presented.
1057-Pos Structural and Biophysical
Studies of the Interactions of
Phosphatidylinostiol 3-kinase C2a with
Clathrin
David P. Chimento1, Thomas J. Murray1, James Bedison1,
Yanqui Zhao2, James H. Keen2, Kathryn M. Fereguson1
1University Of Pennsylvania, Philadelphia, PA, USA
2 Thomas Jefferson University, Philadelphia, PA, USA.
Board B33
We are interested in the potential regulatory role of the phospha-
tidylinostiol 3-kinase C2a (PI3K-C2a) in clathrin assembly and
trafficking events. PI3K-C2a co-localizes with clathrin, and exoge-
nous expression of PI3K-C2a affects clathrin-mediated endocytosis
and sorting to the trans-Golgi network. Further, the association of
clathrinwith PI3K-C2a stimulates the kinase activity.Manyclathrin
interacting proteins contain a consensus sequence called a “clathrin-
box” that mediates interaction with the terminal domain (TD) of the
clathrin heavy chain. We are investigating the role of the clathrin-
box and other possible binding regions from the N-terminal clathrin
binding domain of PI3K-C2a for interactions with the clathrin
terminal and ankle domains.
We have determined the X-ray crystal structure of a complex of
the clathrin TD (amino acids 2-363; TD363) with amino acids 24-
135 of PI3K-C2a (PI3K-C2a(24-135)). We observe only 6 amino
acids of PI3K-C2a(24-135), located in a hydrophobic binding
groove previously identified as the binding site for “clathrin-box”
peptides. Surprisingly we find that this bound fragment is not the
previously defined clathrin box (box1) of PI3K-C2a. Rather we
identified a degenerate “clathrin-box” sequence (DLMVFP) that we
term box2.
Surface plasmon resonance (SPR, Biacore) studies of PI3K-C2a
(24-135) binding to TD363 show that this interaction is relatively
weak (Kd ~ 100 mM) and dominated by clathrin box2. In further
exploring the interaction of PI3K-C2a with clathrin we have
observed higher affinity interactions (Kd ~ 1–5 mM) using either
longer PI3K-C2a fragments, or clathrin fragments that comprise the
terminal domain plus amino acids extending into the clathrin ankle
domain. We anticipate that multiple contact points, each individu-
ally of rather low affinity, cooperate to form a stable complex
between the PI3K-C2a and clathrin. Progress towards structural
characterization of these multiple binding sites will be described.
1058-Pos Understanding the Mechanism
of the Anti-angiogenic Activity of
Suramin
Khalil Ibrahim, Karuppanan M. Kathir, Thallapuranam K.
Kumar
University of Arkansas, Fayetteville, AR, USA.
Board B34
Angiogenesis is a cellular process that involves the sprouting of new
blood vessels from pre-existing ones. Fibroblast growth factors
(FGFs) play a crucial role in the regulation for angiogenesis and
tumor metastases. Therefore, intensive research efforts are on to
develop drugs that can specifically inhibit FGF-induced angiogen-
esis. FGFs exhibit their cell proliferation activity by binding to the
extracellular D2 domain of their cell surface receptor. Suramin
({carbonyl bis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1
phenylene)carbonylimino]}-bis(1,3,5-naphthalenetrisulfonic acid)
hexasodium salt) has been previously shown to inhibit FGF-induced
tumors. In this context, in the present study, we investigate the
interaction of suramin with the extracellular D2 domain of the FGF
receptor (FGFR). Results of the isothermal titration calorimetry
(ITC) experiments suggest that suramin binds to the D2 domain of
FGFR with a reasonably high affinity (Kd ~ 10
6 M). ITC experi-
ments, carried out a various salt concentrations, showed that sur-
amin-D2 domain interaction is mostly stabilized by ionic interac-
tions. Size exclusion chromatography profiles of the D2 domain,
obtained in the presence and absence of suramin, show that the drug
binds to the receptor domain in a 1:1 stoichiometry. Equilibrium
unfolding experiments monitored by far UV circular dichroism
reveal that the D2 domain is significantly stabilized by suramin.
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1H-15N chemical shift perturbation data show that the suramin
binding sites are mostly contributed by residues located at the N-
and C-terminal ends of the D2 domain. Interestingly, some of the
residues that bind to suramin are located at the FGF-D2 domain
interface. Therefore, it appears that suramin inhibits the cell prolif-
eration activity of FGF by preventing its interactionwith FGFR. The
results of this study are expected to paveway for a rational design of
drugs against FGF-induced tumors.
1059-Pos Dimerization Of The Fgfr Is
Prerequisite For Fgf Signaling
Ryan Thurman, Rajalingam Dakshinamurthy, Fei Guo,
Joshua Sakon, Suresh Kumar Krishnaswamy
Thallampuranam
University of Arkansas, Fayetteville, AR, USA.
Board B35
Fibroblast growth factors (FGFs) are ~ 16 kDa heparin binding
proteins that regulate key cellular processes such as angiogenesis,
differentiation, morphogenesis, wound healing and tumor growth.
FGFRs consist of three extracellular ligand binding domains (D1,
D2, D3), a single transmembrane helix, and cytoplasmic tyrosine
kinase domain. Cell surface-bound HSPGs (heparan sulfate pro-
teoglycans) supported dimerization or polymerization of the FGFRs
are thought to be required to activate the signaling pathway. The D2
domain is suggested to bind with both HSPGs and FGFs to form a
ternary complex. Recent X-ray crystallography data has showed D2
domain formed a crystallographic 2-fold symmetry dimer with the
interface residues including Y155 and which is different from other
crystallographic studies of FGFRs. In this study, D2-Y155 has been
mutated and characterized using various biophysical techniques
including multidimensional NMR spectroscopy. Results from ther-
mal denaturation studies using fluorescence and circular dichroism
indicates that the D2-Y155A mutation reduced the melting temper-
ature of the protein by 10C to14 C to result in a Tm of 38 C. Urea
and guanidine hydrochloride induced denaturation also confirm a
significant destabilization of protein caused by theY155Amutation.
Isothermal titration calorimetry (ITC) experiments of D2-Y155A
with sucrose octasulfate (SOS) indicates a reduced binding affinity
(Kd ~ 4.78 mM)when compared to the D2 (Kd ~2.59 mM)wild type.
1060-Pos Understanding the Molecular
Mechanism Underlying the Auto
Inhibition of the Fibroblast Growth
Factor Signaling
Lindsay Rutherford, D. Rajalingam, T. K. S. Kumar*
Department of Chemistry and Biochemistry, University of Arkansas,
Fayetteville, AR.
Board B36
Fibroblast growth factors (FGFs) are heparin binding proteins that
help regulate key cellular processes such as wound healing and
differentiation. The FGF signaling is generated by the binding of the
ligand (FGF) to the extracellular domain of the FGFR, this binding
induces dimerization of FGFR, which is an essential step in FGF
signaling. Fibroblast growth factor receptor (FGFR) extracellular
domain consists of three Ig domains D1, D2, and D3. Between the
Domains D1 and D2 is a short span of acidic residues called the
“acid box”. The D1-D2 linker is thought to play a role in regulation
of FGF interaction with FGFR. Many of the FGF binding sites can
be found on the extracellular D2 domain of the receptor. It is
believed that “acid box” can regulate FGF binding to FGFR. The
“acid box” can mimic heparin like compounds and bind at the
heparin binding sites located on the surface of the D2 region of
FGFR. In the present study, we synthesized a twenty-eight amino
acid box region peptide and studied its interaction with D2 domain
of FGFR using various biophysical techniques including multidi-
mensional NMR spectroscopy.Our results clearly show that the acid
box peptide binds to the ligand binding domain of the fibroblast
growth factor receptor.
1061-Pos Molecular cloning,
Overexpression and Biophysical
Characterization of D3 domain of
Fibroblast Growth Factor Receptor
TRINH D. TRAN, Rajalingam Dakshinamurthy,
Thallapuranam Krishnaswamy Sureshkumar
UNIVERSITY OF ARKANSAS, Fayetteville, AR, USA.
Board B37
Fibroblast growth factor receptor (FGFR) is comprised of a trans-
membrane domain, a cytoplasmic domain, which is responsible for
the tyrosine kinase activity, and an extracellular ligand-binding
domain. The ligand-binding domain consists of three immunoglob-
ulin-like domains (D1, D2, andD3). The FGF signaling is generated
by the binding of the ligand (FGF) to the extracellular domain of the
FGFR.Ligand binding induces dimerization of FGFR,which proves
to be an essential step in FGF signaling. The D3 domain determines
the specificity of the ligand binding (FGF binding), while the D2
domain includes the primary site for ligand and heparin binding. In
this study for the first time, we report the cloning, expression,
biophysical, and biological characterization of the D3 domain of
FGFR2. D3 domain has been expressed in Escherichia coli in high
yields. The protein was purified to homogeneity using affinity
chromatography. Results of the steady-state fluorescence experi-
ment show that the recombinant D3 domain is in a folded confor-
mation. Far-UV circular dichroism (CD) data suggest that D3
domain is an all beta-sheet protein. The findings of the present
study not only pave way for an in-depth structural investigation of
the molecular mechanism(s) underlying the interaction of FGFwith
D3 domain but also provide avenues for developing agonists and
antagonists for the treatment of FGF-induced pathogenesis.
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1062-Pos Understanding the Role of
Divalent Cations in FGF Signaling
Karuppanan M. Kathir, Sivaraja Vaithiyalingam, Suresh
Kumar K. Thallapuranam
University of Arkansas, Fayetteville, AR, USA.
Board B38
FibroblastGrowth Factors are importantmolecules that regulate key
biological processes such as, limb regeneration, wound healing and
tumor growth. FGFs require heparin or heparin sulfate to activate
their transmembrane receptor (FGFR). FGFR is composed of three
immunoglobulin (Ig)-like domains (D1, D2 and D3). The ligand
(FGF) - induced dimerization of FGFR leads to the juxtaposition of
the cytoplasmic tyrosine kinase domain and its subsequent trans
autophosphorylation. However, very little is known on the exact
events involved in the regulation of FGF signaling process. Previous
studies had shown that divalent cations bind to the D2 domain of
FGFR. The bound cations have been shown to regulate the mito-
genic activity of FGF. In addition, copper is known to be involved in
non-classical FGF release. In this study, we investigate the role of
divalent cations (Cu2þ, Zn2þ) in modulating the structural events
leading to FGF signaling. Isothermal titration calorimetry (ITC)
experiments reveal that the divalent cations bind to the D2 domain
with high affinity. Results of the Far UV circular dichroism and
steady state fluorescence experiments reveal that the metal ions
trigger a significant conformational change in the D2 domain. The
divalent cation binding sites on the D2 domain have been mapped
using 1H-15N chemical shift perturbation. The divalent metal ions
appear to increase binding affinity of sucrose octa sulfate (SOS), a
structural analogue of heparin, to theD2 domain. Results of ITC and
1H-15N chemical shift perturbation experiments show that affinity of
theD2domain to bind to FGFdecreases significantly in the presence
of the divalent cations. The results of our study for the first time
elucidate the role of divalent cations in the regulation of the FGF
signaling process.
1063-Pos Interplay Between the
Intracellular Domain of Amyloid
Precursor Protein and Wnt Signaling
Fangfang Zhou1, Xiufang Zhang1, Nanming Zhao1, Huaxi
Xu2, Yeguang Chen1, Yandao Gong1
1 Tsinghua University, Beijing, China
2 The Burnham Institute, La Jolla, CA, USA.
Board B39
Amyloid precursor protein (APP), a key protein in pathogenesis of
Alzheimer’s disease (AD), is a type I transmembrane protein which
can be cleaved by b- and g-secretase to release the amyloidogenic b-
amyloid peptides (Ab) and the APP intracellular domain (AICD).
While Ab has been widely believed to initiate pathogenic cascades
culminating AD, the physiological functions of AICD remain
elusive. Here, we demonstrate that the AICD, independent of Fe65,
is stabilized by canonical Wnt signaling mediated by b-catenin and
then the accumulated AICD inversely inhibits Wnt signaling by
enhancing the kinase activity of GSK3b through interacting with
GSK3b and enforcing the association of GSK3b and Axin. Further-
more, based on the inhibition of Wnt signaling, AICD induces the
promoter activity and protein expression of CDK inhibitors: p15,
p16 and p21 with or without NGF stimulation, inhibiting the cell
proliferation and facilitating the neurite outgrowth in neural PC12
and N2a cells.
1064-Pos The Activation and Repression
of YlaC, ECF Sigma Factor, by
Formation of Disulfide Bond in YlaD,
Anti-sigma Factor, and Adding Mn2þ
Ions at Condition on Interaction of YlaC
and YlaD in B. subtilis
Han-Bong Ryu, InJi Shin, Hyung-Soon Yim, Sa-Ouk Kang
Seoul National University, Seoul, Republic of Korea.
Board B40
YlaC, one of seven ECF sigma factors ofB. subtilis, has the function
of gene expression for response to oxidative stress agent such as
hydrogen peroxide or diamide. YlaD, anti-sigma factor of YlaC, is
membrane protein having HX3Cys-X-X-Cys motif acting as oxida-
tive stress sensing domain and ZAS family (zinc-binding anti-sigma
factor) in Streptomyces coelicolor. We now report that purified
YlaC interacts with purified YlaD in vitro by oxidized and reduced
state of YlaD or adding Mn2þ ions at condition on interaction of
YlaC and YlaD. Reduced YlaD obtained by DTT treatment at YlaD
binds toYlaC. Reversely, YlaC is released from interaction between
YlaC and YlaD when oxidizing agent such as hydrogen peroxide or
diamide added. Also, adding Mn2þ ions at condition on interaction
of YlaC and YlaD obtains the same results as oxidizing reagents
treatment at YlaD. These interactions of YlaC and YlaD in vitro
studies indicate that redox state of YlaD is critical for YlaD binding
to YlaC and Mn2þ ions release YlaC from YlaD binding to YlaC.
Also, in vitro transcription studies compensate for results of inter-
action of YlaC and YlaD in vitro studies. Two promoters, Pyla and
Spx-dependent, have existence in the ylaABCD operon. It is known
that Spx-dependent promoter responds to oxidative stress. Pyla
promoter is not known. YlaC induces transcription from Pyla and
Spx-dependent promoter. Hydrogen peroxide and diamide induce
the transcription of ylaC transcripts but ylaA transcripts did not
induced. These results suggest that YlaC may induce the transcrip-
tion from Pyla and Spx-dependent promoter by different mechanism
of releasing YlaC from YlaD binding to YlaC
1065-Pos TheAllosteric Effect of a Single
Point Mutation Can be Summed Up in
One Individual Subunit of B.
stearothermophilus
Phosphofructokinase
Stephanie Perez, Gregory D. Reinhart
Texas A&M Univ, College Station, TX, USA.
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Gly184 is a key residue in conferring the allosteric response in
Bacillus stearothermophilus PFK (BsPFK). As compared to wild-
type, the substitution G184C has been shown to have a seven-fold
decrease for PEP inhibition inBsPFK at 25C. To further investigate
how this alteration disrupts the complex inhibition pathway, the
mutation was introduced into one subunit of hybrid tetramers that
isolate the individual heterotropic interactions for BsPFK: 23A

,
30A

, 33A

, 45A

. The effect of G184C in each individual interaction
was determined and compared to wild-type. In BsPFK, the four
heterotropic interactions isolated in these hybrids account for the
heterotropic inhibition observed for both wild-type and G184C. In
the 32A

interaction, there was a two-fold decrease in PEP inhibition
and a less dramatic decrease was seen in the 22A

interaction. There
was almost no change in PEP inhibition observed in the remaining
30A

and 45A

heterotropic interactions. The allosteric effects of
single perturbations in BsPFK have previously been thought to have
a more global affect in the tetramer, however, this is the first residue
shown to contain its effects in the single mutated subunit.
Supported by grant GM33216 from NIH and grant A1543 from
the Welch Foundation.
1066-Pos Short Electronegative
Sequences Mediate Binding of Obscurin
to sAnk1
Benjamin R. Busby, Maegen A. Borzok, Aikaterini
Konstrogianni-Konstantopoulos, Robert J. Bloch
University of Maryland, Baltimore, Baltimore, MD, USA.
Board B42
Obscurin is a 6,620 amino acid protein that surrounds the contractile
apparatus at M-bands and Z-disks. It has been proposed to link the
contractile apparatus to network sarcoplasmic reticulum (nSR) by
binding via its C-terminal domain to a small form of ankyrin
(sAnk1), an integral protein of the nSR. Two regions in the C-
terminus have been shown to bind sAnk1, but their binding char-
acteristics have not been compared quantitatively. We generated
GST fusion constructs, and prepared biotinylated, synthetic pep-
tides of the 30 residue minimal binding sequences of each, and
assayed their binding to sAnk1 fusion constructs by surface plasmon
resonance. Histagged sAnk129–155 constriucts bound to the
Obsc6316–6345 peptide with 90 nM affinity, whereas they bound to
the Obsc6231–6260 peptide with a much higher KD (lower affinity).
When the minimal binding region of sAnk1, sAnk160–130 was
assayed, the Obsc6231–6260 peptide binding became even weaker,
but there was no significant change in binding of Obsc6316–6345. We
obtained similar results using fusion protein constructs of the
obscurin sequences, rather than oligopeptides. We also assayed the
ability of the synthetic peptides in solution to inhibit binding.
Consistent with our direct binding assays, the Obsc6316–6345 peptide
was several-fold more potent an inhibitor than Obsc6231–6260, when
tested against fusion proteins containing either sequence. Finally,
we studied the ability of both constructs to bind to eight mutants of
sAnk1. We found that mutants of sAnk1 modulated binding of
sAnk1 to both constructs similarly. Our results suggest that
Obsc6316–6345 predominates in binding to sAnk1, but that the same
residues on sAnk1 that bind to this sequence with high affinity also
bind to Obsc6231–6260, albeit with lower affinity. We find it remark-
able that a 6620-residue protein requires  30 amino acids to bind
with nM affinity to a membrane ligand.
1067-Pos Identifying peptides that bind
to the C-terminus of erythroid beta
spectrin using a phage display
Chloe Antoniou1, Yuanli Song1, Sang Thai2, AdnanMemic2,
Brian K. Kay2, L. W.-M. Fung1
1Department of Chemistry and
2Department of Biological Sciences, University of Illinois at Chicago, 845
West Taylor Street, Chicago, IL, 60607, USA.
Board B43
Spectrin is a major cytoskeletal protein in a wide-range of cells that
consists of alpha and beta subunits that form functional tetramers.
Recently, spectrin isoforms have been shown to interact with many
proteins in neuronal cells both as an alpha-beta complex and as
individual subunits. Proteins that associate with beta spectrin in
neurons include, amongst others, ankyrin, various types of sodium
and calcium channel, neurofascin, protein kinase C, other cytoskel-
etal proteins etc. We have focused on the tetramerization region of
spectrin in the cytoskeleton. A recombinant protein of the C-
terminal region of beta spectrin was used as a target protein to
screen for interacting peptides. A library of 10-amino acid peptides
displayed on phages was used, and we have identified six peptides
that bound to our target protein. The peptides were then synthesized
and characterized by circular dichroism. Their association with
spectrin isoforms were studied by isothermal titration calorimetry
methods to further explore the interactions. The effects of these
peptides on alpha and beta spectrin association will be discussed.
1068-Pos Molecular Simulation of the
Scorpion BmP02 with the Small-
conductance Calcium-activated
Potassium Channels
Mehriar Amininasab1, Maryam Rouhani2
1Department of cell andmolecular biology, Faculty of science,University of
Tehran, Tehran, Iran (Islamic Republic of)
2Department of biophysics, Faculty of science, University of Tarbiat-
moddaress, Tehran, Iran (Islamic Republic of).
Board B44
The interaction of scorpion toxin BmP02 from Buthus martensi
karsch with a small conductance calcium activated potassium chan-
nel rsk2 was simulated in the following steps. In the first step the
overall orientation of the toxin with respect to rsk2 was determined
according to the default Brownian dynamics algorithm implemented
in the MACRODOX simulation package. Among all with the mini-
mum potential energies of interactions, two modes of binding were
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identified, selected and utilized as the starting complexes for the
second step of simulations. In this step a 5 ns molecular dynamics
simulations was performed in NPT conditions on each selected
model using the GROMACS simulation package, version 3.3.1.
In general, the BD simulation and subsequent molecular dynam-
ics refinement reveals the critical residues for the recognition and
interaction between BmP02 and rsk2 complexes.
1069-Pos Calmodulin and Calcineurin:
Mechanisms of Molecular Recognition
Susan E. O’Donnell, Madeline A. Shea
University of Iowa, Iowa City, IA, USA.
Board B45
Cardiac hypertrophy results from stress on cardiomyocytes, which
contributes to heart failure. Calcineurin (CaN) is a dimeric Ser/Thr
phosphatase, which when constitutively active, induces hypertro-
phic responses. The activity of CaN is controlled by intracellular
calcium and requires calmodulin (CaM), a major Ca2þ sensor in
eukaryotes. The individual roles of the two homologous domain of
CaM in the activation CaN are not known.
Thermodynamic properties governing the interactions of CaN
and CaM were studied. Fluorescence anisotropy was used to
determine the binding affinity of CaM for a peptide (CaNp),
representing the CaM-binding domain of CaN subunit A. Dissocia-
tion constants (Kd) were determined for the N-domain (CaM1–80),
C-domain (CaM76–148) and full-length form of CaM (CaM1–148) in
the presence and absence of saturating calcium (10 mM). Calcium-
saturated CaM1–148 had a significantly higher affinity for CaNp than
either of its two domains, with an estimated Kd of 1 pM. Domain-
specific mutants of CaM were studied to determine how mutations
between and within Ca2þ-binding sites alter the interactions be-
tween CaM and CaNp.
Fluorescence-monitored equilibrium calcium titrations of CaM1–
148, CaM1–80, and CaM76–148 showed how CaNp affected the Ca
2þ-
binding properties of CaM. The Ca2þ affinity of the N- and C-
domain sites of CaM1–148 increased significantly with the greater
effect on the N-domain, evidently through interdomain cooperativ-
ity. Studies of mutants revealed that CaNp significantly improved
the Ca2þ-binding properties of both domains of CaM1–148 mutants,
while there was little effect on corresponding domain fragments.
Thus, CaNp restored the Ca2þ-binding properties of CaM1–148
mutants, even when residues located in the Ca2þ-binding sites were
compromised.
Support by UI CBB to SEO, NIH R01 GM57001 to MAS.
1070-Pos Potentiation and Inhibition of
the nACHR alpha 7 subtype by choline
and a spirofuropyridine alpha 7 agonist
David Gurley, Jeff Smith, Tim Piser
Astrazeneca, Wilmington, DE, USA.
Board B46
The a7 neuronal nicotinic receptor (a7 nAChR) is a homopenta-
meric ligand-gated ion channel expressed in mammalian central
nervous system regions associated with cognitive processing. a7-
selective agonists have demonstrated activity in rodent models of
cognition. A hallmark of a7 receptor activation is rapid activation
and desensitization, occuring on the order of milliseconds. Also,
pre-application of agonists appear to inhibit subsequent ACH-
mediated current by desensitization. Potency for desensitization of
the receptor is much higher then potency to activate the receptor.
Choline is a full agonist on the a7-homomeric subtype (Papke et
al., 1996). Additionally, on the a4b4 nACHR subtype, choline was
shown to potentiate ACH-mediated currents (Zwart and Vijverberg,
2000). We further explored the activity of choline on the rat a7
receptor expressed in xenopus oocytes. Brief incubations with
choline, at biologically relevant concentrations, much lower than
those necessary to directly gate the a7 receptor, potentiated current
mediated by low concentrations of ACH (30microM). Also, per-
forming dose-response experiments with ACh revealed that co-
application with choline resulted in a pronounced leftward shift in
the ACH concentration-effect curve.
AZ1 is an a7-selective agonist with EC50 for activation in the
high nanoM range when measured by net charge transfer and low
microM range when measured by peak on rat a7. However, positive
behavioural effects with this compound occur at plasma concentra-
tions as low as 1.5nM, well below threshold for eliciting observ-
able channel activation.We found that, like choline,AZ1potentiates
ACh-mediated current from a7 at concentrations well below those
needed for direct activation of the receptor. These results provide a
novel mechanism we call, positive orthosteric modulation, to
explain behavioral effects observed with doses of AZ1 that are
unlikely to elicit channel opening in vivo.
1071-PosAModel for the Interaction of a
Long chain alpha-neurotoxin with
Muscle type nAChR
adak Nasiripourdori, Bijan Ranjbar, Hossein Naderi-manesh
Tarbiat modares university, tehran, Iran (Islamic Republic of).
Board B47
Molecular dynamics simulations of a model of ligand binding
domain of Torpedo nicotinic acetylcholine receptor in complex
with a long-chain alpha-neurotoxin from Naja Naja oxiana is
conducted. The model is based on muscle type nAChR(2BG9)
resolved by electron microscopy which appears to exist under the
basal or resting state.Two simulations are run,one is receptor with
toxin as a ligand and the other is receptor free of ligand, in order to
give insight into the details of the interactions and conformational
changes upon binding of a long-chain neurotoxin to the nAChR.Our
docking results confirm the claim that T.nAChR (2BG9) is in basal
or resting state, which favors binding to the alpha neurotoxins.
Details of interaction shows that the long chain alpha neurotoxin
interacts in somanyways similiar to that of otherwell-characterized
alpha neurotoxins, such as alpha-bungaro toxin and alpha-cobra-
toxin. The main structural changes seen upon binding of neurotoxin
compared to the apo formof nAChR,is that ligand-bonded nAChR is
more compact and less dynamic in certain domains compared to the
apo form.Most changes and dynamic motions are seen in loops and
the lowes part of the LBD.the most distinctive loop motion appears
to be that of the C-loop, the main constituent of binding site.In the
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binding site, motions are much restricted and residues are more
ordered in the presence of the ligand bound. In addition, some
critical interactions in the binding site are studied, e.g. the triad of
K145/D200/Y190.the salt bridge formed between K145/D200 re-
mains intact and is even stabilized during the 5 nsecMD simulation,
while it is obviously more labile in apo form.This is in agreement
with the claim that alpha neurotoxins stabilize the resting state.
1072-Pos Interactions of the Anti-
Psychotic Drug Trifluoperazine with
Calmodulin and its Effects on Calcium
Binding Affinity
Michael D. Feldkamp, Madeline A. Shea
Univeristy of Iowa, Iowa City, IA, USA.
Board B48
The anti-psychotic drug trifluoperazine (TFP) is an antagonist of
calmodulin (CaM), binding in its hydrophobic clefts. Three crystal
structures of TFP bound to calcium-CaM show 1, 2 or 4 TFP per
CaM, but the RMSD of their backbones is < 1 A˜.... Their con-
formations are similar to CaM bound to CaMKII peptide, which
increases the calcium affinity of CaM. However, the energetics of
TFP binding to CaM, its effects on calcium binding, and possible
interactions with apo (calcium-depleted) CaM are controversial.
Equilibrium calcium titrations monitored by changes in steady-
state fluorescence of intrinsic Phe and Tyr residues were used to
evaluate the effect of TFP on the calcium affinity of full length CaM
(CaM1-148), N-domain (CaM1-80) and C-domain (CaM76-148)
over a range of TFP:CaM ratios. Despite similarities between
structures of CaM-TFP and CaM-peptide complexes, low levels of
TFP (1:1, 2:1 ratios) decreased the calcium affinity of CaM.TFP had
the greatest effect on calcium binding to sites III and IV, in the C-
domain of CaM1-148, but affected both domains. At an 8:1 ratio of
TFP:CaM, the effect reversed and the calcium affinity of CaM
increased.
Stoichiometric titrations of TFP binding to CaM monitored by
1H-15N-HSQCNMR also identified the C-domain of CaM1-148 as
most perturbed by TFP, whether apo or calcium-saturated. The
maximal stoichiometry of TFP binding to apo CaM1-148 was 3:1;
for calcium-CaM, it was 4:1. Addition of calcium to apoCaM1-148-
TFP caused significant perturbation to the 1H-15N-HSQC spec-
trum, indicating the structure of apo CaM1-148 bound to TFP
changed significantly upon calcium binding. This demonstrated
that the TFP-CaM interfaces respond to calcium ligation, and that
there is a hierarchy of binding TFP to its multiple sites.
Supported by NIH GM57001.
1073-Pos Thermodynamics of Nickel Ion
Binding to Human Growth Hormone
Ali Akbar Saboury, Safora Amiri
Institute of Biochemistry andBiophysics, University of Tehran, Tehran, Iran
(Islamic Republic of).
Board B49
Human growth hormone (hGH) is a single domain globular protein
containing 191 amino acids and approximately molecular mass of
22 kDa. hGH plays an important role in somatic growth through its
effects on the metabolism of proteins, carbohydrates and lipids.
Following our reports recently on the binding properties and
structural changes of hGH due to its interaction with a number of
metal ions, a binding study of nickel ions by hormone has been done
at 27C in NaCl solution (50 mM) using an isothermal titration
calorimetry. There is a set of three identical and noninteracting
binding sites for nickel ions. The intrinsic dissociation equilibrium
constant and themolar enthalpy of binding are 40 mMand16.5 kJ/
mol, respectively. Thermodynamic parameters of nickel ion binding
are compared to the other metal ions. The molar entropy of binding
is 29.3 J K1 mol1 for Ni2þ, less than of Cu2þ and more than of
Ca2þ, Mg2þ, Fe3þ and Co2þ, means that the disorder of the protein
structure due to the binding of nickel ions is more than to the other
ion metals studied, except Cu2þ. From spectroscopic data, it is
expected that nickel ions can prevent from the aggregation of the
hormone.
1074-Pos Role of Annexin in the Non-
Classical Secretion Signal Peptide-less
Proteins
Anna E. Daily, Rajalingam Dakshinamurthy, Suresh Kumar
Krishnaswamy Thallampuranam
University of Arkansas, Fayetteville, AR, USA.
Board B50
Members of the S100 family of proteins are involved in a variety of
calcium-signaling events and various human diseases such as cystic
fibrosis, cardiomyophathy, and several types of cancer. S100A13, a
member of the S100 family, exhibits ubiquitous expression in a
broad range of tissues. S100A13 is known to be involved in the non-
classical export of signal peptide-less proteins such as fibroblast
growth factor (FGF-1) and interleukin-1Iˆ– across the cell mem-
brane. To achieve non-classical transport, S100A13, in complex
with a signal peptide-less protein, binds to annexin II which exhibits
an inducible flip-flop mechanism across the cell bilayer and by
which helps the multiprotein release complex to traverse the mem-
brane bilayer. In the present study the interaction of S100A13 and
annexin II is characterized using various biophysical techniques
including multidimensional NMR spectroscopy. We identified and
synthesized using solid-phase peptide synthesis techniques a 15-
amino acid N-terminal region of the annexin II, which bind to
severalmembers of S100 family. Fluorescence titration experiments
on apo-S100 and calcium bound form with annexin II indicate that
the annexin II peptide binds strongly to holo-S100A13 compared
with apo-S100A13. Results of the intrinsic tryptophan fluorescence,
isothermal calorimetry (ITC), Circular Dichroism (CD), and mul-
tidimensional NMR experiments will be discussed in detail.
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1075-Pos Conformational Regulation of
Soluble Guanylate Cyclase
Jasmin Kristianto, Yu-Hsi Chang, Raymond M. Esquerra,
Nancy C. Gerber
san francisco state university, San francisco, CA, USA.
Board B51
Soluble Guanylate Cyclase (sGC), a member of the nucleotide
cyclase family, is the principal physiological receptor of Nitric
Oxide (NO) with primary function to catalyze the formation of
cGMP fromGTP.UponNObinding, the enzyme’s activity increases
by almost 400-fold, and the produced cGMP acts as a second
messenger, regulating the physiological function of several impor-
tant enzymes that promote vasodilation, smooth muscle relaxation,
and platelet aggregation.Carbonmonoxide has also been implicated
as a signaling molecule acting through sGC, although it appears to
require the presence of an allosteric effector to achieve full activa-
tion. Although the structure of sGC has not been elucidated, it is
known to be a heme containing heterodimer with alpha and beta
subunits. Our experimental objective is to understand the confor-
mational changes of the enzyme upon activation by NO and CO and
how the allosteric regulation occurs. Using both fluorescence
spectroscopy and Magnetic Circular Dichroism (MCD), we probed
the different conformational complexes occurring in sGC upon
activation by NO, CO and the effector YC-1. MANT-GTP, a
fluorescence analog of GTP, was also utilized to examine the
enzyme’s active site. Despite the similar levels of activity, the NO
and CO/YC-1 bound enzymes are structurally distinct. MCD mea-
surements showed the sGC heme forming a 6-coordinate complex
upon binding with CO/YC-1; a structure indistinguishable from
carbonmonoxy Myoglobin, while adopting a 5-coordinate complex
in the presence of NO. The distinction was further confirmed via
fluorescence spectroscopy of the four endogenous Tryptophans.
Using fluorescence, we have also determined that YC-1 binds at a
distance of 60 A

from the heme, within close proximity to the GTP
binding site. Collectively, the data has allowed us to propose a
mechanism on the allosteric regulation employed to fully activate
sGC via the CO and NO gasses.
1076-Pos Structural and Biophysical
Basis of Poxvirus Interaction with Host
Cell-Surface Chondroitin Sulfate
Joseph Schoeniger1, Masood Hadi1, Brent Segelke2, Diana
Roe1, Yooli Light1, Marites Ayson1, Adam Zemla3
1 Sandia Labs, Livermore, CA, USA
2 Lawrence Livermore National Labs, Livermore, CA, USA
3 Lawrence Livermore National Lab, Livermore, CA, USA.
Board B52
Binding to cell-surface carbohydrates is a critical step in the
interaction of orthpoxviruses with host cells. Inhibiting the activity
of the chondroitin sulfate (CS) binding protein D8L present on the
surface of Vaccinia intracellular mature virus (IMV) greatly attenu-
ates cell-binding and infectivity. D8L and a structurally dissimilar
heparan sulfate binding protein H3L are two of a small number of
IMV membrane proteins known to stimulate production of neutral-
izing antibodies. Most genes, including those encoding CS-binding
proteins are, highly homologous across the orthopoxviridae. Since
gross-sequence differences cannot be used to generate discriminat-
ing antibodies, understanding the structural and biophysical basis of
the interaction of these proteins with their cell-surface receptor
ligand and other small molecules can assist efforts to improve
affinity reagents to detect the biothreat agent smallpox and discrim-
inate it from other pox viruses. Such understanding may also form
the basis for developing improved vaccines or new antipox drugs.
Based on homology models, we identified a positively charged CS-
binding groove on the protein surface, and predicted residues
involved inCS binding.We usedCS-binding assays and calorimetry
to characterize CS-binding affinity and stability of purified recom-
binant wild-type and site-specific mutants of CS-binding protein
expressed in E. coli. We experimentally identified key amino acids
involved in CS binding, confirming many of our predictions, and
other residues important for binding and protein stability. We
recently determined an X-ray structure of CS-binding protein,
minus its transmembrane anchor, at a resolution of 1.6 Angstroms.
This is one of only two structures of a poxvirus IMV membrane
protein. We will discuss implications of the structure for the
molecular mechanism of CS-binding, potential of the protein as
a drug target, and possibility using this information to develop
affinity reagents for discriminating between orthopoxviruses.
1077-Pos Molecular Interactions In The
ccd Addiction System
Natalie De Jonge, Lieven Buts, Abel Garcia-Pino, Lode
Wyns, Remy Loris
VUB, Brussels, Belgium.
Board B53
Plasmid addiction systems consist of a plasmid-encoded toxin:
antidote pair that serves to stabilize low-copy number plasmids in
bacterial populations. The ccd addiction module on the E. coli
plasmid F was the first TA module described and the first for which
the mode of action of its toxin was elucidated. It encodes a toxin,
CcdB, that targets DNA gyrase, and an antitoxin, CcdA, that can
antagonize CcdB by forming a non-covalent complex.We analyzed
the molecular interactions within the ccd system by means of a
series of biophysical techniques and crystallography. The crystal
structure of CcdB in complex with the C-terminal domain of CcdA
shows an entity with a 2:1 CcdB:CcdA stoichiometry in which the
CcdA domain is wrapped around the CcdB dimer in a largely alpha-
helical conformation. Binding studies between CcdB and CcdA-
derived peptides are indicative of a system with negative coopera-
tivity in which the first ligand binds with high (picomolar) affinity
and the second ligand with a substationally reduced (micromolar)
affinity. This negative cooperativity is compatible with our crystal
structure as binding of a second C-terminal part would require a
conformational change in at least one of the proteins to avoid steric
overlap. As the CcdA and gyrase-binding site of CcdB do not
overlap, the rejuvenation mechanism of CcdA probably occurs
though an allosteric mechanism rather than through competitive
inhibition.
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1078-Pos Biophysical Characterization
of Human Interleukin 1a
Rajalingam Dakshinamurthy, Suresh Kumar Krishnaswamy
Thallapuranam
University of arkansas, Fayetteville, AR, USA.
Board B54
Interleukin-1a is a 19 kDa protein that plays a crucial role in the
regulation of a number of key cellular processes. IL-1a is a cytokine
and a potentmediator of body’s response to inflammation,microbial
invasion, tissue injury, and immunological response. Recent studies
also suggest that IL-1a also has a role in wound healing,
Alzheimer’s disease and tumor growth. Interestingly, unlike many
other proteins, IL-1a lacks the N-terminal signal peptide and has
been shown to be secreted through a non-classical route, which is
independent of the conventionalER-Golgi secretory pathway. IL-1a
is secreted into the extracellular compartment as a binary complex
with S100A13, calciumbinding protein. The non-classical secretion
of IL-1a is proposed as ideal model to understand the ER-Golgi
independent secretion of a large number of proteins that lack the N-
terminal signal sequence. In this study for the first time, we report
the cloning, expression, biophysical, and biological characteriza-
tion of the human interleukin-1a. Human IL-1a has been expressed
in Escherichia coli in high yields and purified to homogeneity using
affinity chromatography. Results of the steady-state fluorescence,
far-UV circular dichroism and 2D NMR experiments show that the
recombinant IL-1a is in a folded conformation. Recombinant IL-1a
was observed to exhibit strong cytostatic effect on human umbilical
vascular endothelial cells. ITC experiments show that the recombi-
nant IL-1a binds strongly to S100A13, a calcium binding protein
that chaperones the in vivo release of IL-1a into the extracellular
compartment. Using 1H-15N chemical shift perturbation data, the
IL-1a binding sites on the S100A13 have been successfullymapped.
The findings of the present study not only pave way for an in-depth
structural investigation of the molecular mechanism(s) underlying
the non-classical release of IL-1a but also provide avenues for the
rational design of potent inhibitors against IL-1a mediated
pathogenesis.
1079-Pos Anesthetic Interaction Sites in
Closed- and Open-channels of nAChR
(a4)2(b2)3
LU Tian Liu, Yan Xu, Pei Tang*
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Board B55
Nicotinic acetylcholine receptors (nAChR) are putative anesthetic
targets. Because of its abundance in brain and high sensitivity to
anesthetics, the nAChR (a4)2(b2)3 was chosen for searching for
anesthetic binding sites and understanding how anesthetics modu-
late the receptor functions. Halothane binding in the (a4)2(b2)3 in
closed- and open-channel conformations were examined using
AutoDock under various docking conditions. For both channel
conformations, the halothane binding energy was in the range of
3.23.9 Kcal/mol. Over 60% of halothane binding occurred in
the interfacial region between the extracellular and transmembrane
(TM) domains, including the Cys loops, b1–2 loops, and TM2-3
loops. The majority of remaining halothane-binding sites were
found in the extracelluar domain, mainly in the MIR region and
some in theA loops. Less than 2%of halothane bindingwas found in
the TM domain of the closed conformation, but no binding site was
found in the TM domain of the open state. A noticeable difference
between the two conformations was that halothane bound to inter-
subunit regions (a4/b2 and b2/b2) only in the closed state. The
binding sites could be perturbed by even subtle protein structure
changes, as evidenced in the fact that one of b2 subunits had no
halothane binding in both closed- and open channel models. A close
inspection of halothane binding sites indicated an amphiphilic
nature of the sites consisting of both hydrophobic and polar hydro-
philic (both neutral and charged) residues. Many of these results are
in good agreement with previous findings from photoaffinity label-
ing experiments. Substantial halothane binding in the interfacial
region of the (a4)2(b2)3 implicates the potential roles of anesthetics
in destructing signal transduction from agonist binding in the
extracellular domain to channel gating.
Supported by NIH (R01GM66358 and R01GM56257) and
NCSA through the PSC.
1080-Pos Collagen Binding Domain - As
a novel drug delivery of Parathyroid
Hormone (PTH)
Sagaya TLeena Philominathan1,OsamuMatsushita2, Robert
Gensure3, Joshua Sakon1
1University of Arkansas, Fayetteville, AR, USA
2Kitasato University, Sagamihara, Japan
3Ochsner Children’s Hospital, New Orleans, LA, USA.
Board B56
Monthly injection of parathyroid hormone (PTH) fused to CBD can
increase bone mineral density (BMD) by 15% in mice within 2
months. PTH marketed not only needs to be injected daily but also
will require a year to achieve the BMD increase. Pharmacokinetics
of PTH-CBD is under investigation. To better understand the role of
CBD in the pharmacokinetics and to help us to further optimize in
PTH-CBD, through biophysical studies were conducted. For exam-
ple, CBD with tighter binding to collagen may increase BMD even
faster. Collagen binding domain (CBD), a C-terminal segment of
bacterial collagenase (ColG) is responsible recognizing and binding
to collagen triple helix. CBD binds tighter to collagen in the
presence of Ca2þ (5.72 105M). X-ray crystal structure is solved
for CBD at 1.35A

resolution. Extensive mutagenesis of the con-
served surface residues in CBD, in conjunction with collagen-
binding studies identified key residues involved in CBD:collagen
binding interface. Three possible collagen orientations on CBD
were proposed based on the study. Since attempts to co-crystallize
CBDand collagen did not yield crystals,NMRmethodswere used to
determine the precise orientation of collagen on CBD. Titration
results identified the involvement of additional residues on CBD in
collagen binding and ruled out one of the earlier binding models we
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proposed. Interestingly the binding surface identified is concave that
could force collagen to be bent.
1081-Pos Mechanism Of Calmodulin
Association With Connexin32 Derived
Peptides
Ryan Dodd, Daniel Stolady, Zawahir Chowdhury, Gerald
Connolly, Camillo Peracchia, Katalin Torok
SGUL, London, United Kingdom.
Board B57
Calmodulin (CaM) has been shown tomodulate the chemical gating
of gap junction channels1. Two calmodulin binding regions have
been previously described in connexin32 (Cx32), one in the N-
terminal and another in the C-terminal tail1,2. Using Ca2þ binding-
deficient CaM mutants, CaM12 and CaM34, we have investigated
the interaction of the N and C-lobe CaM Ca2þ binding sites with
Cx32 derived peptides by stopped-flow kinetics at pH 7.0 at
physiological ionic strength and 2 mM Mg2þ. Interaction with
Cx32 1–19 was found to engage all 4 Ca2þ binding sites. The CaM
C-lobe showed higher affinity (Ca2þ dissociation rate constant (koff)
3.6 – 0.03 s1) than the N-lobe (koff 56 – 1.8 s1). In contrast, Cx32
208–226 at 10 mMonly affected the C-lobe CaMCa2þ binding sites
(koff 6.1 – 0.1 s1). At 20 mM, however, 3 Ca2þ sites were involved:
the Ca2þ binding sites of the C-lobe (koff1 11.6 – 0.4 s1 and koff2
1.67 – 0.05 s1) and anN-lobe site (koff 11.6 – 0.4 s1). Dissociation
constantKd values were 1 and 3.4 mMCaM for Cx32 1–19 and 208–
226, respectively. CaM conformation as measured by FRET3 in the
complexes was semi-compact which together with the Ca2þ kinetic
data suggests separate functions for the C- and N-terminal lobes for
CaM. Our data show that the C-terminal Cx32 208–226 peptide
binds one CaM lobe only and suggest trans-domain CaM binding as
a possible mechanism for chemical gating of gap junctions.
This work is supported by the Wellcome Trust.
References
1. Peracchia, C. BBA (2004)1662, 61–80.
2. Torok et al., Biochem J. (1997) 326, 479–483.
3. Torok et al., Biochemistry (2001) 40, 14878–14890.
Protein Physical Chemistry
1082-Pos Entropy Definition of Non-
Equilibrium Biological Macromolecules
David V. Svintradze
Tbilisi State University, Tbilisi, Georgia.
Board B58
Novel entropy definition for non-equilibrium biological macromo-
lecules will be proposed in this paper and shown that non-equilibri-
um systems like biological macromolecules can form stable states.
Also summary temperature of non-equilibrium systems will be
defined and clarified that in such systems each sub-system has
different temperature. Entropy of the systemcouldn’t be 0 at 0 0K, i.e
generally thermodynamics third low couldn’t be right for non-
equilibrium systems. Let take single biological macromolecule
situated in a virtual closed box as a closed system and define entropy
of such system. Let consider that one of the principal determinants
of biomacromolecular structures’ are intermolecular hydrogen
bonds and discuss some sub-system where number of hydrogen
bonds are n, assuming that in hydrogen bonds AiH—Bi (i¼1,2...n)
proton has two possible energetic levels E0 and E (or two possible
quantum states), first corresponds to non-formation of hydrogen
bonds and second corresponds to involving of proton in hydrogen
bonds with energy E. So there could be some kind of swinging of
proton between two energetic negative atoms Ai and Bi by hole
effect, where time of this swinging could be appropriate time for
protons during the effect. The relaxation time of such hydrogen
bonds will be endlessness thus proton will never stand on one
energetic level in hydrogen bonds. If it is considered that such
formalism of hydrogen bonds is correct then it could be said that:
1. it is non-equilibrium state;
2. degree oˆ of non-equilibrium state of the sub-system is propor-
tional to number of hydrogen bonds involved in this sub-
system; and
3. entropy is a function of two parameters E and oˆ, S¼S(E,oˆ).
Thus finally we will suggest conclusions that different parts of
biological macromolecules could have different temperature and
entropy could not be 0 at 0 0K.
1083-Pos A Geometric Construction To
Aid In Qualitative Analysis Of Ternary
Mixture Phase Separation Conditions
George M. Thurston, David S. Ross
Rochester Institute of Technology, Rochester, NY, USA.
Board B59
Understanding the molecular origins of the phase boundaries of eye
lens protein solutions can help us understand loss of transparency of
the eye lens in cataract disease, the leading cause of blindness. It has
recently been found that eye lens alpha and gamma crystallin
mixtures need finely tuned interactions to avoid opacity, in that
thermodynamic stability of their highly concentrated mixtures
depends non-monotonically on alpha/gamma interaction
strength[1]. Experiment and theory have long shown that ternary
mixture phase separation typically depends non-monotonically on
molecular interaction strengths. Here we present a geometric con-
struction to aid qualitative analysis of phase separation conditions,
in the space of the three independent components of the Hessian of
the intensiveGibbs free energy. In the simplest mean-fieldmodels, a
generic non-monotonic dependence of stability on interaction
strengths is associated with conic sections formed by the intersec-
tion of planes with the elliptical cone of spinodal conditions. A
similar construction can help in analyzing more complicated,
realistic free energy models.
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